In this event, we will introduce biotech startups with novel technologies and seeds from Kyoto University, Japan. We aim to connect US investors to Japanese academia-oriented startup companies. This will be an excellent opportunity to discover promising startups still in their early stages.

The technologies and seeds in the following fields:

• Pharmaceuticals
• Diagnostics
• Regenerative medicine
• Medical devices

The event schedule:

• 9:00 am Registration
• 9:30 am Opening remark
• 9:50 am Showcase (15min presentation and 25min discussion/each)
• 12:00 pm Lunch
• 1:00 pm Showcase (15min presentation and 25min discussion/each)
• 3:10 pm Reception (Networking)
• 5:00 pm Adjourn

For details, ask at kurcsd@mail2.adm.kyoto-u.ac.jp.

Presenting companies:

9:50-10:30

• Department of Drug Discovery for Lung Diseases, Kyoto University - Innovate the drug discovery for respiratory diseases using iPS-cell technology

10:30-11:10

• Therabiopharma - Development of curcumin monoglucuronide (CMG) as an anticancer drug for phase I/II clinical trials of refractory and rare cancers, glioblastoma and drug-resistant multiple myeloma

11:20-12:00

• Cyfuse Biomedical - Creation of functional tissue with a novel scaffold-free bio 3D printing technology

13:00-13:40

• Quadlytics - Offering epilepsy patients world's first clinically approved seizure prediction software

13:40-14:20

• Oligogen - Development of drug and cell therapy products using novel human neural stem cells “OligoGenie”

14:30-15:10

• KinoPharma - Innovative therapeutic drug development for cervical intraepithelial neoplasia (CIN) through industry-university collaboration

Commentators:

• Susie Harborth (COO, BioLabs; COO/CFO, Mission BioCapital)
• Jay Kunin, PhD (Boards of PharmaSecure, Inc. and Sironis, Inc.)
• Daria Mochly-Rosen, PhD (Professor of Chemical and Systems Biology at the Stanford University, Stanford SPARK)
• Charles E Prussak, PhD (Director of the Cell Therapy Translational Laboratory (CTTL), UCSD)
• Lada Rasochova, PhD, MBA (Executive Director, California Institute for Innovation and Development (CIID), Rady School of Management, UCSD)

Cosponsored by

• Life Science Innovation Network Japan (LINK-J)

Supported by

• Japan Agency for Medical Research and Development (AMED)
• Foundation for Biomedical Research and Innovation at Kobe (FBRI)
• Japan External Trade Organization (JETRO)
• Japan Forum for Innovation and Technology, UCSD (JFIT)
• Japan Science and Technology Agency (JST)
• Science and Innovation for the Next Generation (SING)